HerAnova Lifesciences

Home
United States
Burlington, MA
HerAnova Lifesciences

We are advancing innovative women’s health solutions with a focus on endometriosis and infertility.

09/03/2026

Who may be a candidate? How does testing work? What do the results mean?

CNY Fertility answers these questions and more in its article on HerResolve™, our non-invasive blood test designed to aid in the diagnosis of endometriosis in symptomatic women of reproductive age, including those experiencing unexplained infertility.

Beyond the testing workflow, the article shows how HerResolve™ fits within the broader clinical picture, including how results may be considered alongside symptoms, medical history, imaging, and prior treatment outcomes. It also addresses how the test compares with laparoscopy and other diagnostic approaches.

We appreciate CNY Fertility for incorporating HerResolve™ into clinical practice and sharing a detailed resource for patients considering endometriosis testing!

Read the full article: https://www.cnyfertility.com/herresolve-endometriosis-blood-test/

08/31/2026

When infertility is "unexplained," could endometriosis be a contributing factor?

Dr. Mary Peavey of Atlantic Fertility joined Dr Aimee Eyvazzadeh on The Egg Whisperer Show to explore why endometriosis is often overlooked in fertility care and how HerResolve™, our non-invasive blood test, offers clinicians another tool to aid in its diagnosis.

Dr. Peavey discusses who may benefit from testing and how identifying endometriosis may help guide fertility treatment decisions, including after an unsuccessful embryo transfer.

Thank you to Dr. Peavey for sharing her clinical experience with HerResolve™ and to Dr. Eyvazzadeh for making this important discussion accessible to patients and providers!

Tune in to the full episode: https://draimee.org/a-new-blood-test-for-endometriosis-with-guest-dr-mary-peavey

08/28/2026

Today, we remember Dolly Parton, whose extraordinary talent, generosity, and warmth touched generations. From her legendary music and storytelling to her work expanding access to books for children, her impact reached far beyond the stage.

Dolly also lived with endometriosis, an often-invisible disease affecting millions. Her experience reminds us that even when a life is known around the world, the realities of endometriosis can remain largely unseen.

As we honor Dolly's remarkable life and enduring legacy, we also recognize everyone living with endometriosis and the pain, uncertainty, and disruption the disease can bring.

Our thoughts are with her family, friends, and all who loved her.

08/27/2026

Endometriosis does not always look the way it feels.

Dr. Farideh Bischoff, HerAnova’s Chief Medical Officer, joined Dr. Mohammad Ali, host of the Xtalks Life Science Podcast, to discuss why symptom severity does not always reflect the extent of disease and why endometriosis can be so difficult to diagnose.

Dr. Bischoff explains why smaller superficial lesions and early-stage disease can be harder to detect with ultrasound or MRI. She also explores how multi-omic approaches and AI are being used in non-invasive diagnostic research, while underscoring the need to validate new tests across different patient populations.

Thank you to Dr. Ali for the thoughtful interview and to Soumya Shashikumar for capturing the key takeaways in the accompanying write-up!

Catch the full episode: https://xtalks.com/why-endometriosis-can-be-so-difficult-to-diagnose-with-heranova-s-dr-farideh-bischoff-episode-265-4927/

08/24/2026

You know your body better than anyone else.

Tracking your symptoms, recognizing patterns, and noting how they affect your daily life can support a more meaningful conversation with your healthcare provider.

A symptom journal can help capture when pain occurs, how long it lasts, and what makes it better or worse.

At HerAnova, we're committed to pioneering diagnostics that give healthcare providers additional insights to support informed decision-making.

Learn more about HerResolve™, our blood test to detect endometriosis: https://heranova.com/products/

08/20/2026

A great conversation on the evolving approach to endometriosis detection and care. Thank you, Dr. Aimee Eyvazzadeh, for helping bring greater awareness to this important topic, and Dr. Mary Peavey for sharing your clinical perspective and experience with HerResolve™.

We’re grateful to both of you for advancing the conversation around earlier answers for women with endometriosis. 💜

08/11/2026

What are biomarkers, and why are they important in endometriosis research?

Endometriosis is a complex disease involving inflammation, hormonal signaling, and changes in the immune system. Because no single biomarker tells the whole story, researchers are studying combinations of molecular markers to better understand the disease.

Our recently published research explores a multi-omic approach that combines microRNAs, protein biomarkers, and a steroid hormone marker with machine learning to aid in the detection of endometriosis.

This research marks an important step toward improving how endometriosis is identified and managed.

Read the peer-reviewed publication in JMIG (The Journal of Minimally Invasive Gynecology): https://www.jmig.org/article/S1553-4650(26)00151-2/fulltext

08/07/2026

Painful, heavy, or disruptive periods should not automatically be dismissed as "normal."

Persistent symptoms can be signs of conditions such as endometriosis, fibroids, or adenomyosis, yet many women still wait years for answers.

Our goal is to encourage symptom recognition and productive conversations that support better care.

If your symptoms don't feel normal, trust your instincts and talk with a healthcare provider.

The Endometriosis Foundation of America offers tips for preparing for that conversation: https://www.endofound.org/preparing-to-see-a-doctor

08/05/2026

Endometriosis is associated with infertility, yet many patients still spend years searching for answers. Research suggests that up to 50% of women with infertility have endometriosis.

The effects can extend across the care journey:
• For patients: prolonged uncertainty can take an emotional and physical toll
• For providers: limited diagnostic clarity can complicate clinical recommendations and shared decision-making
• For healthcare systems: repeated appointments and testing can add complexity

Earlier insight into gynecologic health may support more informed conversations, treatment decisions, and fertility care planning.

At HerAnova, we believe advancing women's health starts at the front of the care pathway.

07/30/2026

At 38, a patient with unexplained infertility was preparing for another IVF cycle. She had no clear imaging evidence of endometriosis and reported no classic signs or pain symptoms, despite a family history of the disease.

Her provider incorporated HerResolve™ as part of the patient's broader clinical evaluation. The results contributed additional information that helped guide discussions around next steps and care planning, which involved surgical management before IVF in her case, with the goal to improve likelihood of success.

Every fertility journey is different, and access to additional clinical insights may help support individualized care strategy.

That is the goal behind our HerResolve™, a non-invasive blood test designed to help identify endometriosis earlier in a patient’s fertility journey.

Learn more: https://heranova.com/products/

Address

2 Burlington Woods Drive Suite 100
Burlington, MA
01803

Telephone

+18884891808

Website

http://heranova.com/

Alerts

Be the first to know and let us send you an email when HerAnova Lifesciences posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to HerAnova Lifesciences:

Want your business to be the top-listed Health & Beauty Business in Burlington?